EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+6.2%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$308M
AUM Growth
+$308M
(+3.1%)
Cap. Flow
+$6.11M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
96.57%
Holding
15
New
2
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
Snowflake
SNOW
|
$11.4M |
| 2 |
Nurix Therapeutics
NRIX
|
$4.1M |
| 3 |
Pinduoduo
PDD
|
$207K |
| 4 |
Vir Biotechnology
VIR
|
$95 |
Top Sells
| 1 |
PMV Pharmaceuticals
PMVP
|
$9.25M |
| 2 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$339K |
Sector Composition
| 1 | Healthcare | 94.56% |
| 2 | Technology | 3.7% |
| 3 | Financials | 1.33% |
| 4 | Consumer Discretionary | 0.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PMV Pharmaceuticals
PMVP
$74.2M
| $134M | 43.34% |
3,908,677
-270,739
| -6% | -$9.25M |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $29.4M | 9.56% |
1,493,349
| – | – |
|
3
Denali Therapeutics
DNLI
$2.23B
| $25.4M | 8.24% |
323,749
| – | – |
|
4
RAPT Therapeutics
RAPT
$188M
| $23.4M | 7.59% |
735,801
| – | – |
|
5
Alector
ALEC
$238M
| $20.4M | 6.63% |
980,894
| – | – |
|
|
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $18.7M | 6.08% |
554,325
| – | – |
|
7
Oric Pharmaceuticals
ORIC
$994M
| $17.6M | 5.72% |
996,734
| – | – |
|
8
Foghorn Therapeutics
FHTX
$286M
| $13.5M | 4.37% |
1,261,261
| – | – |
|
|
9
Snowflake
SNOW
$79.6B
| $11.4M | 3.7% |
+47,136
| New | +$11.4M |
|
10
First Financial Bancorp
FFBC
$2.51B
| $4.1M | 1.33% |
173,576
| – | – |
|
|
11
Nurix Therapeutics
NRIX
$714M
| $4.1M | 1.33% |
+154,426
| New | +$4.1M |
|
12
Beam Therapeutics
BEAM
$1.66B
| $4.01M | 1.3% |
31,131
| – | – |
|
|
13
Pinduoduo
PDD
$171B
| $1.25M | 0.4% |
9,806
+1,632
| +20% | +$207K |
|
|
14
Vir Biotechnology
VIR
$686M
| $1.22M | 0.4% |
25,866
+2
| +0% | +$95 |
|
|
RUBY
15
DELISTED
Rubius Therapeutics, Inc
RUBY
| – | – |
-12,791
| Closed | -$339K |
|